SI-BONE, Inc. (SIBN): Revenue

Annual figures by period end, from SEC filings.

$200.93M
Year ended 2025-12-31
$213.60M
Trailing 12 months to 2026-06-30
+23.6%
3-year compound annual growth
+22.3%
5-year compound annual growth
2017-12-31: $47.98M2018-12-31: $55.38M2019-12-31: $67.30M2020-12-31: $73.39M2021-12-31: $90.15M2022-12-31: $106.41M2023-12-31: $138.89M2024-12-31: $167.18M2025-12-31: $200.93M$200.93M
2017-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$200.93M+20.2%2026-02-24, From 2025-01-01
2024-12-31$167.18M+20.4%2026-02-24, From 2024-01-01
2023-12-31$138.89M+30.5%2026-02-24, From 2023-01-01
2022-12-31$106.41M+18.0%2025-02-25, From 2022-01-01
2021-12-31$90.15M+22.8%2023-03-02, From 2021-01-01
2020-12-31$73.39M+9.0%2022-03-01, From 2020-01-01
2019-12-31$67.30M+21.5%2021-03-10, From 2019-01-01
2018-12-31$55.38M+15.4%2020-03-11, From 2018-01-01
2017-12-31$47.98Mn/a2019-03-14, From 2017-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
SI-BONE, Inc. (SIBN)2025-12-31$200.93M+20.2%
Treace Medical Concepts, Inc. (TMCI)2025-12-31$212.69M+1.6%
Heartflow, Inc. (HTFL)2025-12-31$176.03M+39.9%
Cerus Corp (CERS)2025-12-31$233.80M+16.1%
Orthopediatrics Corp (KIDS)2025-12-31$236.35M+15.4%
Lemaitre Vascular Inc (LMAT)2025-12-31$249.60M+13.5%
Neuronetics, Inc. (STIM)2025-12-31$149.16M+99.2%
InfuSystem Holdings, Inc (INFU)2025-12-31$143.44M+6.4%
SkinHealth Systems Inc. (SKIN)2025-12-31$300.79M-10.0%

Compare SIBN, TMCI, HTFL, CERS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗